Fernando Moreno Antón - Servicio de Oncologia Médica, Hospital Clinico San Carlos

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 43 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract PO3-04-12: SUMIT-BC: Phase 2 randomized study of fulvestrant with or without the cyclin-dependent kinase 7 inhibitor (CDK7i) samuraciclib in advanced hormone receptor positive (HR+) breast cancer after CDK4/6i

Glen Clack,Sercan Aksoy,Meritxell Bellet- Ezquerra,Begoña Bermejo,Cagatay Arslan,Maria Castro-Henriques,Irfan Cicin,Mahmut Gumus, Carmen Hinojo-González,Nuri Karadurmus, Denisse Lee Cervantes,Rebeca Lozano Mejorada,Emmanuel de la Mora Jimenez,Fernando Moreno Antón,Sonia Pernas,Timothy Pluard, Carlos Zuloaga Fernandez del Valle,Ozan yazıcı,Stuart McIntosh

Cancer Researchno. 9_Supplement (2024): PO3-04

Cited0Views0Bibtex

Plasma Mutational Burden in PIK3CA and TP53 Independently Predicts Early Progression in Patients with HR+/HER2- Metastatic Breast Cancer (MBC) Enrolled in the GEICAM/2014-12 FLIPPER Trial

Federico Gustavo,Rojo Todo, Lara Meier,Maria Teresa Martinez, Maria Esteban Lopez,Lorena Paris,Miriam O'Connor,Luis De la Cruz Merino,Ana Santaballa,Noelia Martinez-Janez,Fernando Moreno Anton,Isaura Fernandez,Maccon Keane,Andres Garcia-Palomo,Anna Starus, Marta Portela,Jesus Herranz,Rosalia Caballero,Frederick Jones,Joan Albanell

Journal of Clinical Oncologyno. 16_suppl (2024): 1029-1029

Cited0Views0Bibtex

SUMIT-BC: Phase 2 Randomized Study of Fulvestrant with or Without the Cyclin-Dependent Kinase 7 Inhibitor (cdk7i) Samuraciclib in Advanced Hormone Receptor Positive (HR Plus ) Breast Cancer after CDK4/6i

Glen Clack,Sercan Aksoy,Meritxell Bellet-Ezquerra,Begona Bermejo,Cagatay Arslan,Maria Castro-Henriques,Irfan Cicin,Mahmut Gumus, Carmen Hinojo-Gonzalez,Nuri Karadurmus, Denisse Lee Cervantes,Rebeca Lozano Mejorada,Emmanuel de la Mora Jimenez,Fernando Moreno Anton,Sonia Pernas,Timothy Pluard, Carlos Zuloaga Fernandez del Valle,Ozan Yazici,Stuart McIntosh

CANCER RESEARCHno. 9 (2024)

Cited0Views0Bibtex

Clinical Experience with Abemaciclib in Patients Previously Treated with Another CDK 4/6 Inhibitor in a Tertiary Hospital: A Case Series Study

Alicia Milagros de Luna Aguilar,Javier David Benitez Fuentes,Justo Ortega Anselmi,Jennifer Olalla Inoa,Paloma Flores Navarro,Alfonso Lopez de Sa,Jesus Fuentes Antras,Cristina Rodriguez Rey,Aida Ortega Candil,Fernando Moreno Anton,Jose Angel Garcia Saenz

CANCERSno. 18 (2023)

Cited1Views0WOSBibtex

Primera Línea De Tratamiento Sistémico Del Cáncer De Mama Metastásico Triple Negativo

Julia Tejerina Peces,Fernando Moreno Antón

Revisiones en Cáncer (2023)

Cited0Views0Bibtex

Abstract P6-01-46: Independent Validation of the HER2DX Genomic Test in HER2-positive Breast Cancer Treated with Neoadjuvant Docetaxel, Carboplatin, Trastuzumab +/- Pertuzumab (TCH/TCHP): a Correlative Analysis from a Multicenter Academic Study

Cancer Researchno. 5_Supplement (2023): P6-01

Cited0Views0Bibtex

Independent Validation of the HER2DX Genomic Test in HER2-positive Breast Cancer Treated with Neoadjuvant Docetaxel, Carboplatin, Trastuzumab Plus /- Pertuzumab (TCH/TCHP): a Correlative Analysis from a Multicenter Academic Study

CANCER RESEARCHno. 5 (2023)

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn